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INTRODUCTION
Bhang or cannabis users pose a challenge for the
anaesthetist and it is important that its action on different
body system and possible interaction with the
anaesthetic agents are understood. Cannabis affects
almost every system of the body, particularly the central
nervous system, cardiovascular, respiratory and immune
systems. According to the technical summary report
2013 of Ministry of Narcotics Control Pakistan Bureau of
Statistics, cannabis is the most commonly used drug in
Pakistan and 3.6% of adult population is addicted to
cannabis.1
In this case report, we describe the anaesthetic
management of a patient who was a cannabis addict
along with a review of the pertinent literature.
CASE REPORT
A 35 years old, 60 kg ASA II, male was scheduled for an
emergency fasciotomy following right leg fracture. He
had a history of road traffic accident 2 days before his
admission to the hospital. His past history was
unremarkable except that he had been smoking 5 - 6
cigarettes per day for the last 20 years. He was also a
chronic user of cannabis and had been smoking it 3 to 4
times per week, for the last 20 years. He had not used
cannabis since the accident. He did not admit to any
other addiction besides this.
On general physical examination, he had tachycardia of
130 beats/minute. Other baseline hemodynamic
parameters were blood pressure, 126/84 mmHg,
temperature 37°C and oxygen saturation 99% on room
air. Rest of the physical examination was unremarkable.
Airway assessment revealed poor oral hygiene and
Mallampati class I airway. Baseline laboratory values
showed a haemoglobin value of 12.8 g/dl, hematocrit of
36.8%, creatinine of 1.2 mg/dl, sodium of 136 mmol/l,
potassium of 4.5 mmol/l, chloride of 99 mmol/l and
bicarbonate of 26.0 mmol/l. Liver function tests were
normal.
Before induction of general anaesthesia, standard
monitoring (three lead ECG, oxygen saturation probe,
noninvasive blood pressure monitor) were applied.
Anaesthesia induction was performed with propofol 2
mg/kg, atracurium 0.6 mg/kg and morphine 0.1 mg/kg
(initial dose of 6 mg at induction). Trachea was intubated
with size 8.0 polyvinylchloride tracheal tube and patient's
lungs were ventilated on controlled mode with tidal
volume of 6 ml/kg, respiratory rate of 12 breaths/minute
and FiO2 of 0.4. Anaesthesia was maintained with a
mixture of oxygen/nitrous oxide in a ratio of 40:60.
Isoflurane concentration was kept at 1 MAC and
morphine boluses of 1 mg as required. Infusion of
paracetamol 1 gram IV was given as co-analgesic.
Additional analgesic requirement was assessed, based
on more than 20% rise in blood pressure and heart rate
compared to baseline as well as presence of any
lacrimation and sweating. His requirement for morphine
was seen to be more than average. He received a total
of 10 mg of morphine over 2 hours of surgery. In addition
to morphine, he received ketorolac 30 mg as a bolus
dose. He underwent above knee amputation because of
non-viability of the limb. Intraoperative blood loss was
approximately 800 ml, which was replaced with a
combination of crystalloids and colloids. Rest of
anaesthesia was uneventful.
In the recovery room, patient was comfortable, and vital
signs were stable. He was transfused one unit of packed
cell in the recovery room. He was started on morphine
infusion 2 - 3 mg/hour for postoperative pain
management with infusion of paracetamol 1 gram 6
hourly as co-analgesic. He received a total of 72 mg
morphine in first 24 hours postoperatively and 48 mg on
second postoperative day, which showed an increased
requirement for opioids.
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DISCUSSION
Bhang (also known as Cannabis indica) is a mild
preparation of marijuana made from young leaves and
stems of the cannabis plant. In Pakistan, Bhang grows
wild all over Potohar plateau, Khyber Pukhtunkhwa
province and northern areas. According to an estimate,
in Pakistan, almost 5.8% of the adult population and
approximately 6.4 million person or one in every 27
person is using drugs while nearly 25% of youth are
involved in some form of drug abuse.1 Cannabis is easily
available and its addiction is common especially in some
rural areas. It is, therefore, important that history of drug
abuse is sought from patients at time of pre-operative
assessment and if there is history of cannabis use then
the anaesthetist should ask about the frequency of use
and the time since last use.2 There is a possibility that
because of social implications patient may be reluctant
in disclosing this fact. This patient did reveal his history
of smoking Bhang for the last 20 years.
There are several anaesthesia related concerns in these
patients mainly due to the effects of Tetra Hydrocannabiol
(THC) and its metabolites, and two cannaboids;
cannabidiol and cannabinol, on the different body
systems. The tissue elimination half-life of THC is
approximately 7 days and the total elimination may take
up to 30 days.3 The main concern are its effects on the
cardiovascular system. Low to moderate doses increase
sympathetic activity and decreases parasympathetic
activity and cardiac output.4 In high doses it depresses
the sympathetic system and can cause hypotension.
Chronic use of cannabis can lead to bradycardia as THC
causes depression of calcium dependent ATPase
activity in cardiac muscle.5
ECG of drug abuser may show premature ventricular
contraction, reversible ST and T wave changes or
decreased voltage of P-waves.2,6 THC augments the
effects of drugs that cause cardiac depression and
addition of potent inhalational agents may lead to further
myocardial depression. This patient did not have a pre-
operative ECG done but had tachycardia (130 beats/
minute) on pre-operative examination. His surgical
pathology could be contributory to this tachycardia but it
did not entirely explain it as the patient was afebrile.
Addiction to cannabis smoking can also lead to chronic
cough, airway irritability, wheeze and bronchitis.4,5 There
have been reports of upper airway oedema particularly
uvular oedema in these addicts to the extent that airway
obstruction may occur.7 Some authors recommend
prophylactic use of dexamethasone.8 Early morning
sputum production is 144% greater in cannabis smokers
than non-smokers.9 This patient did not give a history of
any respiratory problems.
Cannabis use has implications for use of anaesthetic
drugs particularly barbiturates, opioids, prostaglandin
inhibitors, benzodiazepines and phenothiazine.4,10
Cannabinol is a potent prostaglandin inhibitor.2 The
effect of above mentioned drugs can be potentiated in
an addicted patient. We did not use barbiturates in this
patient and he received propofol. There was no increase
in the duration of action of this drug in this patient.
An observation in this patient was the increase in narcotic
requirements both intra and postoperatively. He received
a total of 10 mg of morphine (approximately 0.15 mg/kg)
over a period of 2 hours, in addition to one gram of
paracetamol and 0.5 mg/kg ketorolac intraoperatively.
His postoperative narcotic requirement was 72 mg in the
first 24 hours (approximately 3 mgs/hour) despite
receiving paracetamol 1 gram six hourly regularly. This
was nearly double the requirements of an average
patient of same body weight and height. The trend for
higher requirement for morphine continued into the
second postoperative day.
As far as use of muscle relaxants is concerned, THC
depletes acetyl choline stores and has an anticholinergic
effect. It will, therefore, cause potentiation of non-
depolarizing muscle relaxants. Atracurium was used in
this patient which did not cause any problem related to
reversal of neuromuscular block.
Serum levels of cannabis could not be determined in this
patient due to cost implications. It is acknowledged as a
limitation of this report.
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